Frost & Sullivan Independent Equity Research

Revolutionary technology enables cardiologists to make better decisions and results in 30% assumed revenue growth by the end of 2019; Itamar Medical has a $6.8B addressable market with limited competition; we start our coverage with a price target of 1.51 NIS.


Company: Itamar Medical        

Sector: Healthcare

Report type: Initiation Report

Published on: June 26, 2019